Search Results - "Dulman, Robin"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2
  3. 3

    Lung Opacification by Teo, Wan-Yee, Dulman, Robin Y, Vinh, Tuyethoa

    “…Teo et al talks about a case of a 16-year-old girl, who presents with acute left shoulder pain, left-sided chest pain, and shortness of breath, with a history…”
    Get full text
    Journal Article
  4. 4

    High Hydroxyurea Usage in Sickle Cell Anemia Regardless of Patient Demographic by Phan, Vivian, Park, Ju Ae, Dulman, Robin Yates, Lewis, Angela, Briere, Noravy, Notarangelo, Bailey, Yang, Elizabeth

    Published in Blood (02-11-2023)
    “…Introduction/Background: Hydroxyurea is highly effective in sickle cell disease, yet it is still underutilized. The Pediatric Sickle Cell Program of Northern…”
    Get full text
    Journal Article
  5. 5

    High hydroxyurea usage in sickle cell anemia regardless of patient demographics by Phan, Vivian, Park, Ju Ae, Dulman, Robin, Lewis, Angela, Briere, Noravy, Notarangelo, Bailey, Yang, Elizabeth

    Published in Pediatric blood & cancer (01-02-2024)
    “…Hydroxyurea is highly effective in sickle cell disease, but it is still underutilized. Reports of hydroxyurea utilization largely use Medicaid data, and…”
    Get full text
    Journal Article
  6. 6

    Prospective longitudinal follow‐up of children with sickle cell disease treated with hydroxyurea since infancy by Thomas, Ronay, Dulman, Robin, Lewis, Angela, Notarangelo, Bailey, Yang, Elizabeth

    Published in Pediatric blood & cancer (01-09-2019)
    “…Background Hydroxyurea (HU) increases fetal hemoglobin (HgbF) and ameliorates sickle cell disease (SCD) symptoms. Studies have demonstrated the safety and…”
    Get full text
    Journal Article
  7. 7

    Ten‐year longitudinal analysis of hydroxyurea implementation in a pediatric sickle cell program by Phan, Vivian, Park, Ju Ae, Dulman, Robin, Lewis, Angela, Briere, Noravy, Notarangelo, Bailey, Yang, Elizabeth

    Published in European journal of haematology (01-11-2022)
    “…Hydroxyurea (HU) has proven benefit in sickle cell anemia (SCA), but HU is still underutilized. The Pediatric Sickle Cell Program of Northern Virginia…”
    Get full text
    Journal Article
  8. 8

    Outcome of Initiating Hydroxyurea in Infancy for Patients with Sickle Cell Disease 2011-2018 by Thomas, Ronay, Dulman, Robin Yates, Lewis, Angela, Notarangelo, Bailey, Yang, Elizabeth

    Published in Blood (29-11-2018)
    “…Introduction Approximately 2000 babies are born with sickle cell disease annually in the US. Children with severe forms of sickle cell disease (SCD), such as…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Effect of voxelotor on cardiopulmonary testing in youths with sickle cell anemia in a pilot study by Phan, Vivian, Hershenson, Jared, Caldarera, Laura, Larkin, Sandra K., Wheeler, Kari, Cortez, Ana Lucia, Dulman, Robin, Briere, Noravy, Lewis, Angela, Kuypers, Frans A., Yang, Elizabeth

    Published in Pediatric blood & cancer (01-08-2023)
    “…Background Individuals with sickle cell anemia (SCA) exhibit decreased exercise capacity. Anemia limits oxygen‐carrying capacity and affects cardiopulmonary…”
    Get full text
    Journal Article
  11. 11

    The Effect of Voxelotor on Exercise Capacity of Youths with Sickle Cell Anemia by Phan, Vivian, Caldarera, Laura, Cortez, Ana Lucia, Wheeler, Kari, Larkin, Sandra K., Park, Sangah Nancy, Dulman, Robin Yates, Briere, Noravy, Lewis, Angela, Kuypers, Frans A., Hershenson, Jared, Yang, Elizabeth

    Published in Blood (23-11-2021)
    “…Background/Hypothesis: Children and adults with sickle cell anemia (SCA) exhibit decreased cardiopulmonary fitness. Anemia is directly related to oxygen…”
    Get full text
    Journal Article
  12. 12

    Robust immune responses to SARS-CoV-2 in a pediatric patient with B-Cell ALL receiving tisagenlecleucel by Gordon, Oren M., Terpilowski, Madeline, Dulman, Robin, Keller, Michael D., Burbelo, Peter D., Cohen, Jeffrey I., Bollard, Catherine M., Dave, Hema

    Published in Pediatric hematology and oncology (18-08-2022)
    “…Recipients of anti-CD19 targeted therapies such as chimeric antigen receptor (CAR)-T cell are considered at high risk for complicated Severe Acute Respiratory…”
    Get full text
    Journal Article
  13. 13

    Discontinuation of Folic Acid Supplementation in Young Patients With Sickle Cell Anemia by Nguyen, Giang-Kim T, Lewis, Angela, Goldener, Carol, Reed, Brenda, Dulman, Robin Yates, Yang, Elizabeth

    Published in Journal of pediatric hematology/oncology (01-08-2017)
    “…Folic acid (FA) is commonly prescribed for patients with sickle cell anemia, but evidence for the efficacy of this practice is lacking. We stopped FA…”
    Get full text
    Journal Article
  14. 14

    Wild type N-ras displays anti-malignant properties, in part by downregulating decorin by Benet, Marta, Dulman, Robin Yates, Suzme, Raffi, de Miera, Eleazar Vega-Saenz, Vega, Martha E., Nguyen, Thuy, Zavadil, Jiri, Pellicer, Angel

    Published in Journal of cellular physiology (01-06-2012)
    “…Previously, we have shown that wild type N‐ras (wt N‐ras) harbors an anti‐malignant effect against mutated Ras and in tumors without Ras mutations. To…”
    Get full text
    Journal Article
  15. 15

    Splenic infarction due to concomitant hereditary spherocytosis and sickle cell trait by Dulman, Robin Yates, Buchanan, George R, Ginsburg, Howard, Fefferman, Nancy R, Greco, M. Alba, Borys, Dariusz, Blei, Francine

    Published in Journal of pediatric surgery (01-12-2007)
    “…Abstract Concomitant hereditary spherocytosis and sickle cell trait, although extremely rare, could potentially lead to splenic sequestration or infarction. We…”
    Get full text
    Journal Article